Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 7 pseudogene 1 (CCT7P1)
- Target
- CCT7P1
- Molecular classification
- Other (classified as a pseudogene, not a protein-coding gene or functional receptor, enzyme, transporter, etc.)
01
Overview
Chaperonin containing TCP1 subunit 7 pseudogene 1 (CCT7P1) is a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional CCT7 gene but does not encode an active protein. CCT7P1 is sometimes also referred to as CCT7-2P or chaperonin containing TCP1, subunit 7 (eta) pseudogene 1. Unlike the protein-coding CCT7, which is a subunit of the molecular chaperone complex TRiC (TCP1 ring complex) and is involved in ATP-dependent folding of key cytoskeletal proteins such as actin and tubulin, CCT7P1 does not produce a functional protein and is not involved in any recognized biological processes, disease mechanisms, or drug interactions[1][2][6][7][8].
- Other names
- CCT7-2PChaperonin containing TCP1, subunit 7 (eta) pseudogene 1CCT7P1
02
Mechanism of action
None (not a functional protein)
03
Biological functions
None (as a pseudogene, there is no documented biological function; any suggestion of a functional role derives from confusion with the functional gene CCT7)
04
Disease associations
None (as a pseudogene; there are no roles in disease established for CCT7P1)
05
Safety considerations
None (no safety data or therapeutic challenges are relevant to CCT7P1, given its pseudogene status)
06
Interacting drugs
None (no known drugs interact with a pseudogene)
07
Biomarkers
None (there is no evidence supporting CCT7P1 as a biomarker)
Beyond the preview
Go deeper on Chaperonin containing TCP1 subunit 7 pseudogene 1 (CCT7P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 7 pseudogene 1 (CCT7P1).